×
SHIELD 4 Phase 3 Clinical Trial With Orally Administered CCR9 Inhibitor Vercirnon in Crohn's Disease
Keshav S., Schall T., Bekker P.
Type
Conference paper
Publication Date
10/2014
Volume
109
Pages
S498 - S498